Stability of cocaine dose-response functions at different inter-dose intervals.

Pharmacol Biochem Behav

Psychology Department, University of Florida, PO Box 112250, Gainesville, FL 32611, USA.

Published: June 2006

Past research has found that daily administration of cocaine can lead to tolerance to its behavioral effects, and that tolerance can develop even when the dose is varied from day to day. The present experiment examined effects of administering varied doses of cocaine at a variety of inter-dose intervals ranging from once per week to everyday. Pigeons pecked on a fixed-ratio 20 schedule of reinforcement. A dose-response function for cocaine was assessed eight consecutive times during each of four phases of the experiment to assess the stability of effects of each dose. In Phase 1, subjects were administered a dose of cocaine or saline vehicle every seventh day. One subject developed tolerance by the end of this phase and was not studied further. In Phase 2, doses were administered every fourth day. During Phase 3, doses were administered every 2 days. In the final phase, doses were administered everyday. Dose-response curves were generally similar both within and across phases, regardless of inter-dose interval. No subjects developed tolerance during Phases 2, 3, and 4, suggesting that some aspect of the drug regimen prevented the development of tolerance when cocaine was given frequently.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pbb.2006.05.028DOI Listing

Publication Analysis

Top Keywords

phase doses
12
doses administered
12
inter-dose intervals
8
developed tolerance
8
cocaine
5
tolerance
5
phase
5
stability cocaine
4
cocaine dose-response
4
dose-response functions
4

Similar Publications

Background: On demand, topical PrEP is desired by those preferring episodic, nonsystemic PrEP. PC-1005 gel (MIV-150, zinc, and carrageenan) exhibits in vitro antiviral HIV-1, human papillomavirus (HPV), and herpes simplex virus type 2 (HSV-2) activity, attractive for a multipurpose prevention technology candidate. We evaluated the safety, pharmacokinetics, and antiviral effect of rectally applied PC-1005.

View Article and Find Full Text PDF

The development of new and improved antiretroviral therapies that allow for alternative dosing schedules is needed for people living with HIV-1. Islatravir is a deoxyadenosine analog in development for the treatment of HIV-1 that suppresses HIV-1 replication via multiple mechanisms of action, including reverse transcriptase translocation inhibition and delayed chain termination. Islatravir is differentiated from other HIV-1 antiretrovirals by its high potency, long , broad tissue distribution, and favorable drug resistance profile.

View Article and Find Full Text PDF

Monoclonal antibodies (mAbs) are critical components in the therapeutic landscape, but their dosing strategies often evolve post-approval as new data emerge. This review evaluates post-marketing label changes in dosing information for FDA-approved mAbs from January 2015 to September 2024, with a focus on both initial and extended indications. We systematically analyzed dosing modifications, categorizing them into six predefined groups: Dose increases or decreases, inclusion of new patient populations by body weight or age, shifts from body weight-based dosing to fixed regimens, and adjustments in infusion rates.

View Article and Find Full Text PDF

Seed cycling therapy (SCT) involves the consumption of specific seeds during the follicular and luteal phases of the menstrual cycle to help balance reproductive hormones. This study aimed to investigate the effects of SCT on healthy female Wistar albino rats to prevent hormonal imbalances. For SCT, a seed mixture (SM1) consisting of flax, pumpkin, and soybeans (estrogenic seeds) was administered at doses of 5.

View Article and Find Full Text PDF

Origanum syriacum Induces Apoptosis in Lung Cancer Cells by Altering the Ratio of Bax/Bcl2.

Anticancer Agents Med Chem

January 2025

Department of Medical Biochemistry, Faculty of Medicine, Gaziantep University, 27410, Gaziantep, Turkey.

Background: The lung cancer is the leading cause of death worldwide. Although methods such as surgery, chemotherapy, radiotherapy, and immunotherapy are used for treatment, these treatments are sometimes inadequate. In addition, the number of chemotherapeutic agents used is very limited, and it is very important to use new natural agents that can increase the effect of these methods used in treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!